en · de · es · fr · pt
melanotan-2-notes.peptides6823.com › Data › Melanotan-2 Structure And Receptor Pharmacology — Complete Guide

Melanotan-2 Structure And Receptor Pharmacology — Complete Guide

By Editorial Desk · published 2025-10-16 · last reviewed 2025-11-28 · Data

The short version of melanocortin receptor fits in a sentence. The long version — which is the one that helps — is below.

This page was last updated on 2025-11-28 and is reviewed periodically as new material appears.

Melanotan-2 Structure and Receptor Pharmacology

Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.

No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.

Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.

Chemical Background and Receptor Activity

Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.

The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Free base; salt forms add to total mass
Molecular massAbout 1024 daltonsCalculated for the free base
Structural classCyclic heptapeptideContains D-phenylalanine and norleucine
Parent hormoneAlpha-melanocyte-stimulating hormoneEndogenous tridecapeptide of 13 residues
Receptor profileNon-selective melanocortin agonistInteracts with MC1R, MC3R, MC4R and MC5R

Chemistry and Receptor Pharmacology

Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.

Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.

Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.

Related pages on this site

Melanotan II Background and Mechanism

Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.

Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.

Identity and Chemical Background

Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.

The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.

Background and Receptor Mechanism

Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.

Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.

Reference notes

(Auxotrophs are usually not temperature-dependent. They can also depend on other factors.) It is also possible that an organism is auxotrophic to more than just one organic compound that it requires for growth.

=== Color space, dynamic range, frame rate and resolution/aliasing === The human visual system has a limited ability to discern improvements in resolution when picture elements are already small enough or distant enough from the viewer. At some home viewing distances and up to 60-70" TV sizes, HD resolution is near the limits of resolution for the eye and increasing resolution to 4K has little perceptual impact, if consumers are beyond the critical distance (Lechner distance) to appreciate the differences in pixel count between 4K and HD. One exception is that even if resolution surpasses the resolving ability of the human eye, there is still an improvement in the way the image appears due to higher resolutions reducing spatial aliasing. UHDTV provides other image enhancements in addition to pixel density. Specifically, dynamic range and color are greatly enhanced, and these readily resolved saturation and contrast differences greatly improve the experience of 4KTV compared to HDTV. UHDTV allows the use of the Rec. 2020 (UHDTV) color space which can reproduce colors that cannot be shown with the Rec. 709 (HDTV) color space. In terms of CIE 1931 color space, the Rec. 2020 color space covers 75.8%, compared to coverage by the DCI-P3 digital cinema reference projector color space of just 53.6%, 52.1% by Adobe RGB color space, while the Rec. 709 color space covers only 35.9%. UHDTV's increases in dynamic range allow not only brighter highlights but also increased detail in the greyscale. UHDTV also allows for frame rates up to 120 frames per second (fps).

== Gameplay == In Firearms, players are divided into red and blue teams and are tasked with completing objectives. Objectives can vary from controlling areas to destroying objects. The main objective in all maps is to reduce the number of the opponent team's reinforcements to zero. Reinforcements determine the number of times players on a team can respawn. A team loses reinforcements when killed players respawn. The loss of reinforcements on a team can be stifled by completing map objectives and the direct and indirect actions of medics on the team. As long as a team has more than 0 reinforcements, players can respawn instantly. Firearms was the first FPS game to feature player-deployed parachutes. Unlike other games, players are free to choose what weapons they want to use. There are no classes (although players can choose predefined and editable weapon configurations) or a money system used to buy weapons. Instead, Firearms uses a credit system where every player can spend 30 credits on weapons. Every player receives a free knife regardless of the weapons configuration they choose. Players can spend their credits on weapons and equipment, ammunition is free and can be obtained from ammunition boxes available throughout most maps for when a player runs out. Players can buy skills by spending skill points. Every player starts out with 1 skill point and can earn another skill point for every 10 points they have. No more than 7 skill points can be obtained this way. The skill points can be used to buy skills which help the player.

Sources: en.wikipedia.org

Reference notes

== Early life and education == Berhanu Kebede was born in Addis Ababa. He graduated in 1978 with a degree in economics from Addis Ababa University and continued his studies at the Free University of Brussels, earning M.A. degrees in Development Economics (1986) and in Management and Finance (1988).

Vector-based methods have resulted in aggregation and endosomal sequestration of quantum dots while electroporation can damage the semi-conducting particles and aggregate delivered dots in the cytosol. Via cell squeezing, quantum dots can be efficiently delivered without inducing aggregation, trapping material in endosomes, or significant loss of cell viability. Moreover, it has shown that individual quantum dots delivered by this approach are detectable in the cell cytosol, thus illustrating the potential of this technique for single-molecule tracking studies.

=== HLA-DM Structure === The structure and sequence of HLA-DM proteins is very similar to other MHC class II molecules, all of which consist of a heterodimer composed of an alpha and beta chain. However, HLA-DM differs in that it is nonclassical (meaning it lacks a transport signal N-terminus), and does not have the capability to bind peptides. This is due to lack of a deep peptide binding groove – instead, it contains a shallow, negatively charged indent with two disulfide bonds. On its beta chain cytoplasmic tail, a tyrosine-based motif YTPL regulates trafficking to specific endosomal compartments called MHC class II compartments (MIICs) from the ER.

Sources: en.wikipedia.org

Reference notes

The Corps were called into action responding to the Castle Hill convict rebellion. Late on 4 March 1804, a great number of rebels rose up at the government farm at Castle Hill, New South Wales, armed themselves with muskets and pikes from surrounding farms, and planned to sack Parramatta and occupy Sydney Town. An alarm at around 11pm raised Major Johnston from his sleep. He then led 29 soldiers of the New South Wales Corps on a forced march from their barracks at Annandale to Parramatta. They arrived around dawn. Later in the morning, with 50 militiamen of the Loyal Volunteers, they pursued the rebels who were now heading to Green Hills, today's Windsor. At a feigned meeting with the rebels aided by a priest as a lure, Johnston took the ringleaders hostage. When they and their men refused to surrender, to the shouts of 'death or liberty' the troops quickly put down the revolt. Over the next three days, repercussions and summary justice reigned. Governor King highly commended Major Johnston for his actions, even though King had to intervene directly to stop a military kangaroo court from hanging one in ten of the rebels. At midnight on 4 March, Captain Daniel Woodriff of HMS Calcutta landed 150 of his crew to assist the New South Wales Corps and Governor King.

==== Congenital myasthenic syndrome (CMS) ==== CMS is a family of diseases that are characterized by defects in neuromuscular transmission which leads to recurrent bouts of apnea (inability to breathe) that can be fatal. ChAT deficiency is implicated in myasthenia syndromes where the transition problem occurs presynaptically. These syndromes are characterized by the patients' inability to resynthesize acetylcholine.

=== β-meander motif === A simple supersecondary protein topology composed of two or more consecutive antiparallel β-strands linked together by hairpin loops. This motif is common in β-sheets and can be found in several structural architectures including β-barrels and β-propellers. The vast majority of β-meander regions in proteins are found packed against other motifs or sections of the polypeptide chain, forming portions of the hydrophobic core that canonically drives formation of the folded structure. However, several notable exceptions include the Outer Surface Protein A (OspA) variants and the Single Layer β-sheet Proteins (SLBPs) which contain single-layer β-sheets in the absence of a traditional hydrophobic core. These β-rich proteins feature an extended single-layer β-meander β-sheets that are primarily stabilized via inter-β-strand interactions and hydrophobic interactions present in the turn regions connecting individual strands.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan-2 approved for medical use?

No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.

How does melanotan-2 differ from melanotan-1?

Melanotan-1, also called afamelanotide, is a linear analogue with greater selectivity for MC1R and has received approval in some jurisdictions for a specific photosensitivity disorder. Melanotan-2 is cyclic, less selective, and reaches central receptors more readily. The two are often confused in online discussion despite different pharmacology and regulatory status.

What is the connection to alpha-MSH?

Alpha-MSH is an endogenous tridecapeptide derived from pro-opiomelanocortin. Melanotan-2 reproduces its core receptor-binding sequence inside a shortened, stabilised ring. The result is a molecule with a longer effective half-life and higher potency than the parent hormone.

What class of compound is melanotan-2?

It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.

Network